arrow
L

Lisa M. Hillen

Maastricht University Medical Centre
H指数:13
被引数:586

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms

SLFN11在肺小细胞癌、类癌和大细胞神经内分泌癌中的表达分析:对肺神经内分泌肿瘤的见解

2026-07-130
OAAI
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer

25,946例非小细胞肺癌患者中NTRK融合的流行率及特征

2026-06-280
PRE
The Impact of Clinical and Dermoscopic Photographs on the Diagnostic Accuracy of Remote Optical Coherence Tomography Assessment for Basal Cell Carcinoma Detection: A Comparative Diagnostic Study

临床和皮肤镜照片对远程光学相干断层扫描评估基底细胞癌检测诊断准确性的影响:一项比较诊断研究

2025-12-100
OAAI
COMPREHENSIVE ANALYSIS OF NEUROD1, ASCL1, POU2F3 AND YAP1 EXPRESSION SIGNATURES REVEAL UNIQUE LCNEC SUBGROUPS WITH POTENTIAL THERAPEUTIC IMPLICATIONS

对NEUROD1、ASCL1、POU2F3和YAP1表达特征的综合分析揭示了具有潜在治疗意义的独特LCNEC亚群。

2025-09-010
OAAI
Deep Learning–Based Retinoblastoma Protein Subtyping of Pulmonary Large-Cell Neuroendocrine Carcinoma on Small Hematoxylin and Eosin–Stained Specimens

基于深度学习的肺大细胞神经内分泌癌小标本苏木精和伊红染色切片Rb蛋白亚型分类

2025-05-080
OA
OTP, CD4 4, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid
2025-03-010
PRE
Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids

基于免疫组织化学分析的肺类癌定义分子亚组的鉴定及其潜在的治疗易感点

2024-11-014
OAAI
In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma
2021-11-104
OA